Rob Forsyth (@robjforsyth) 's Twitter Profile
Rob Forsyth

@robjforsyth

ID: 14447141

calendar_today19-04-2008 22:39:49

99 Tweet

235 Followers

91 Following

NHS Find Your Place (@nhsfyp) 's Twitter Profile Photo

Take a look at how doctors rated the quality of their training in the 2018 GMC survey Our region is ranked no.1 in England for 16 of 18 indicators! #ItsCannyUpNorth

Take a look at how doctors rated the quality of their training in the 2018 GMC survey

Our region is ranked no.1 in England for 16 of 18 indicators!

#ItsCannyUpNorth
Rob Forsyth (@robjforsyth) 's Twitter Profile Photo

Shout out to #northernrail conductor*s* (one off duty) and esp. driver- imagine what she was thinking emergency braking for Alzheimer lady wandering on track outside #Wigton. Safely retrieved and returned home. Professionalism and a real caring, human response NORTHERN 🚆

Paul Fletcher (@paulpcf22) 's Twitter Profile Photo

Delighted to announce that nobody I know, friend or foe, broadcast any successes this week –grants, jobs, publications or awards Thanks everyone for minimising my anxieties about my own achievementless week Keep it up and let’s go for another triumph-free week starting on Monday

Professor Ian Donald (@iandonald_psych) 's Twitter Profile Photo

1. The govt strategy on #Coronavirus is more refined than those used in other countries and potentially very effective. But it is also riskier and based on a number of assumptions. They need to be correct, and the measures they introduce need to work when they are supposed to.

CRESCENT Trial (@crescenttrial) 's Twitter Profile Photo

Calling research-active UK Paed Emergency Departments! CRESCENT builds on the success of #EcLiPSE working with #PERUKI to deliver an RCT of a novel treatment for #status epilepticus in children PERUKI @mullen_niall Damian Roland Mark Lyttle Liverpool Clinical Trials Centre (LCTC) National Institute for Health and Care Research (1/4)

CRESCENT Trial (@crescenttrial) 's Twitter Profile Photo

Especially in children, brain pH manipulation may be an important, under-estimated means of terminating seizures avoiding respiratory depression and with potential for pre-hospital use (2/4)

CRESCENT Trial (@crescenttrial) 's Twitter Profile Photo

CRESCENT is a double blind RCT comparing inhalation of 100% oxygen vs 95% O2: 5% CO2 for first 10 mins alongside standard APLS management of #status epilepticus. Deferred consent model and outcome collection complete at 24h (3/4)

CRESCENT Trial (@crescenttrial) 's Twitter Profile Photo

Learn more and register your interest in being a participating site at redcapsurveys.uhbw.nhs.uk/surveys/?s=8CP… by end of May 2021 (4/4)

Sacha Altay (@sacha_altay) 's Twitter Profile Photo

April fool’s day sends the wrong message. Being a critical thinker is *not* being skeptical of everything. And critical thinking is *not* only about content but also, and mostly, about the source.

CRESCENT Trial (@crescenttrial) 's Twitter Profile Photo

A superb initial response from UK Paed EDs to CRESCENT: double blind RCT of 100% oxygen vs 95% O2: 5% CO2 for first 10 mins alongside standard APLS management of #status epilepticus. (1/3)

CRESCENT Trial (@crescenttrial) 's Twitter Profile Photo

Epilepsy Action Please RT. Keen to speak with parents with experience of #status epilepticus in their child for any reason. CRESCENT is a clinical trial of a new treatment for #status, opening spring 2022 (1/3)

Rob Forsyth (@robjforsyth) 's Twitter Profile Photo

Improving the evidence base for neurorehabilitation in paediatric acquired brain injury is challenging. Both rehab content and outcomes after ABI are multifaceted. But paying attention to rehab content yields insights (2/3)

Rob Forsyth (@robjforsyth) 's Twitter Profile Photo

Content-aware measures of rehabilitation dose are robustly causally related to pertinent aspects of outcome. These findings are step toward a goal of comparative effectiveness research in pediatric neurorehabilitation (3/3)